Machain-Vázquez RG, Hernández-Marín I

Language: Spanish
References: 11
Page: 83-95
PDF size: 600.57 Kb.

ABSTRACT

Background: Diagnosis of polycystic ovary syndrome (PCOS) in adolescents remains controversial; the 3^rd Amsterdam 2012 Workshop con84 Revista Mexicana de Medicina de la Reproducción Volumen 7, Núm. 2, octubre-diciembre 2014 sensus suggests that the three elements of the Rotterdam criteria must be present in adolescents. The metabolic dysfunction is an important part of the associated risks.
Objective: To determine that the frequency of polycystic ovary syndrome in adolescents attended at service of Biology of Reproduction (BRH) of Hospital Juarez de Mexico that met the criteria of the proposed 3^rd Consensus Workshop Amsterdam 2012 is different than when the 2003 Rotterdam criteria are applied.
Material and method: A cross-sectional study was done from April 2013 to April 2014. The frequency of these two diagnostic criteria and metabolic syndrome between each was studied.
Results: Of the 61 adolescents evaluated, 20 (32.8%) met the proposal of the 3^rd Workshop and 41 (67.2%) with those of Rotterdam. In a subgroup of 37 patients regardless of diagnostic criterion, 21.6% (8) had metabolic syndrome, of whom 5 (62.5%) have the Rotterdam criteria, and 3 (37.5%) the proposal of the 3^rd Workshop. Pearson correlation was directly significant (p 0.01) between the abdominal circumference and the estimation model of insulin resistance (HOMA) in the group evaluated for metabolic syndrome.
Conclusions: The frequency of polycystic ovary syndrome in adolescents attended at Biology of Reproduction service of Hospital Juarez de Mexico is different depending on the diagnostic criteria used, with more adolescents diagnosed with Rotterdam 2003 criteria (67.2%) than with the proposal of the 3^rd Consensus Workshop Amsterdam 2012 (32.8%). Well-designed studies are proposed with the objective of determining the metabolic implications of these results.

REFERENCES

1. Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol 2011;4:45-51.

2. Sheehan MT. Polycystic ovarian syndrome: diagnoses and management. Clin Med Res 2004;2:13-27.

3. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-488.

4. Merino P, Schulin-Zeuthen C, Codner E. Diagnóstico del síndrome de ovario poliquístico: nuevos fenotipos, nuevas incógnitas. Rev Med Chile 2009;137:1071-1080.

5. Organización Panamericana de la Salud. Salud del Adolescente. OPS/OMS, 1995.

6. Rackow BW. Polycystic ovary syndrome in adolescents. Curr Opin Obstet Gynecol 2012;24:281-287.

7. Fauser BC, Tarlatzis BC, Rebar RW, Legros RS, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM- Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28-38.

8. Ságodi L, Barkai L. Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls. Ory Hetil 2013;154:136-142.

9. Blank SK, Helm KD, McCartney CR, Marshall JC. Polycystic ovary syndrome in adolescence. Ann NY Acad Sci 2008;1135:76-84.

10. Moya M. Comorbid states in paediatric and adolescent obesity. A simplified approach to their diagnosis: the metabolic syndrome. An Pediatr 2011;74:289-292.

11. Chielli Pedroso D, Sánchez Melo A, Lucia Carolo A, Sales Vieira C, et al. Frequency and risk factors for metabolic syndrome in adolescents and adults women with polycystic ovary syndrome. Rev Bras Ginecol Obstet 2012;34:357-361.